New Populations with Increased Cardiovascular Risk: Cardiovascular Disease in Dermatological Conditions

The document from 2016 examines the link between certain dermatological diseases and increased cardiovascular risk. It notes that while psoriasis and systemic lupus erythematosus are already recognized in cardiovascular prevention guidelines, other conditions like androgenetic alopecia, polycystic ovary syndrome, hidradenitis suppurativa, and lichen planus also show a higher risk but are not yet included in these guidelines. Androgenetic alopecia is highlighted as an independent risk factor for coronary disease, suggesting early screening and treatment of cardiovascular risk factors in affected patients. The article also discusses the cardiovascular risks associated with dermatological treatments, including both potential adverse effects and cardioprotective benefits, such as those from anti-TNF-α agents. It underscores the need for clinicians to be aware of these risks to provide better care for patients with dermatological conditions. The document does not report any human or animal studies, patient data, funding sources, or conflicts of interest.